BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32299432)

  • 1. Equity, acceptability and feasibility of using polyunsaturated fatty acids in children and adolescents with autism spectrum disorder: a rapid systematic review.
    D'Alò GL; De Crescenzo F; Minozzi S; Morgano GP; Mitrova Z; Scattoni ML; Amato L; Davoli M; Schünemann HJ;
    Health Qual Life Outcomes; 2020 Apr; 18(1):101. PubMed ID: 32299432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review.
    De Crescenzo F; D'Alò GL; Morgano GP; Minozzi S; Mitrova Z; Saulle R; Cruciani F; Fulceri F; Davoli M; Scattoni ML; Nardocci F; Schünemann HJ; Amato L;
    Health Qual Life Outcomes; 2020 Feb; 18(1):28. PubMed ID: 32066439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic review.
    D'Alò GL; De Crescenzo F; Amato L; Cruciani F; Davoli M; Fulceri F; Minozzi S; Mitrova Z; Morgano GP; Nardocci F; Saulle R; Schünemann HJ; Scattoni ML;
    BMC Psychiatry; 2020 Nov; 20(1):561. PubMed ID: 33238921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis.
    D'Alò GL; De Crescenzo F; Amato L; Cruciani F; Davoli M; Fulceri F; Minozzi S; Mitrova Z; Morgano GP; Nardocci F; Saulle R; Schünemann HJ; Scattoni ML;
    Health Qual Life Outcomes; 2021 Jan; 19(1):33. PubMed ID: 33494757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyunsaturated Fatty Acids in Newborn Bloodspots: Associations With Autism Spectrum Disorder and Correlation With Maternal Serum Levels.
    Bostwick A; Snyder NW; Windham GC; Whitman C; Pearl M; Robinson L; Newschaffer CJ; Lyall K
    Autism Res; 2020 Sep; 13(9):1601-1613. PubMed ID: 32897003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.
    Tan ML; Ho JJ; Teh KH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009398. PubMed ID: 23235675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the effect of polyunsaturated fatty acids (PUFAs) on brain plasticity and the improvement on cognition and behavior in individuals with autism spectrum disorder.
    Barón-Mendoza I; González-Arenas A
    Nutr Neurosci; 2022 Feb; 25(2):387-410. PubMed ID: 32338174
    [No Abstract]   [Full Text] [Related]  

  • 12. Memantine for autism spectrum disorder.
    Brignell A; Marraffa C; Williams K; May T
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013845. PubMed ID: 36006807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
    Aye SZ; Ni H; Sein HH; Mon ST; Zheng Q; Wong YKY
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013457. PubMed ID: 33583058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social Stories™ to alleviate challenging behaviour and social difficulties exhibited by children with autism spectrum disorder in mainstream schools: design of a manualised training toolkit and feasibility study for a cluster randomised controlled trial with nested qualitative and cost-effectiveness components.
    Wright B; Marshall D; Adamson J; Ainsworth H; Ali S; Allgar V; Collingridge Moore D; Cook E; Dempster P; Hackney L; McMillan D; Trepél D; Williams C
    Health Technol Assess; 2016 Jan; 20(6):1-258. PubMed ID: 26792796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD012815. PubMed ID: 35766825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials.
    Händel MN; Rohde JF; Rimestad ML; Bandak E; Birkefoss K; Tendal B; Lemcke S; Callesen HE
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat intake in children with autism spectrum disorder in the Mediterranean region (Valencia, Spain).
    Marí-Bauset S; Llopis-González A; Zazpe I; Marí-Sanchis A; Suárez-Varela MM
    Nutr Neurosci; 2016 Nov; 19(9):377-386. PubMed ID: 26020227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.